Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Imbiotechnologies Ltd. is active in the Biotechnology & Pharmaceuticals technology area and has 1 pending office action. This single action indicates that the company is currently in the process of securing patent rights for a specific biotechnological or pharmaceutical innovation. The activity level suggests a targeted prosecution effort.
The prosecution for this company is concentrated in 1 distinct examiner and 1 distinct art unit. This suggests that the technical focus of the company's current work is narrow and fits within a single specialized area at the patent office. For a practitioner, this concentration simplifies the prosecution process, as there is only one examiner's perspective and one art unit's guidelines to consider.
The busiest examiner identified is VU, JAKE MINH, who is responsible for 1 busiest examiner pending office action. Given that this examiner is the only one currently assigned to the company's pending matters, their specific examination style will be a major factor. Practitioners should review the examiner's history in the Biotechnology & Pharmaceuticals area to address the 1 pending action.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VU, JAKE MINH | 1 | 41.1% | +27.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16644142 | SONO-RESPONSIVE EMBOLIC AGENTS | VU, JAKE MINH | 81d overdue |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 16644142 | SONO-RESPONSIVE EMBOLIC AGENTS | VU, JAKE MINH | 1618 | §103 | Final Rejection | 81d overdue | Pending | Mar 03, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial